Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Benoit Visseaux and Paul-Henri Wicky.
Benoit Visseaux
Connection Strength
0.283
Paul-Henri Wicky
  1. Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity". Antimicrob Agents Chemother. 2020 11 17; 64(12).
    View in: PubMed
    Score: 0.057
  2. Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrob Agents Chemother. 2020 10 20; 64(11).
    View in: PubMed
    Score: 0.057
  3. SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients. Crit Care. 2020 10 16; 24(1):610.
    View in: PubMed
    Score: 0.057
  4. Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. J Antimicrob Chemother. 2020 09 01; 75(9):2657-2660.
    View in: PubMed
    Score: 0.056
  5. Case report study of the first five COVID-19 patients treated with remdesivir in France. Int J Infect Dis. 2020 Sep; 98:290-293.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.